GLENMEDE TRUST CO NA - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2020$12,000
+20.0%
1400.0%0.00%
Q2 2020$10,000
-92.5%
140
-91.7%
0.00%
-100.0%
Q1 2020$134,0000.0%1,6840.0%0.00%0.0%
Q4 2019$134,000
+14.5%
1,684
+4.9%
0.00%0.0%
Q3 2019$117,000
+11600.0%
1,605
+10600.0%
0.00%
Q2 2019$1,000150.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders